Zhang et al. [106] found that the level of miR-320a in CAF-derived exosomes of HCC patients was significantly reduced, and in vivo experiments further revealed that miR-320a directly interacted with the downstream target protein PBX3, inhibiting the proliferation and migration of HCC cells by inhibiting the MAPK pathway. This evidence concerns the gene PBX3 and hepatocellular carcinoma.